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2594Dr. Zhu and colleagues also note the different situ-
ations in which the vasovagal reﬂex can occur, and
suggestmatchingwork and life environments between
the placebo and ﬂudrocortisone groups. Although an
interesting and insightful comment, this might not be
practical. Rather, given how often in their daily affairs
patients are subjected to orthostatic stress, the ques-
tion might be why the reﬂex is provoked only occa-
sionally rather than several times daily.
Both questions raise the issue of a more individu-
alized approach to patients, and we suspect that just
such an approach is the key to the successful treat-
ment of vasovagal syncope (2). For this, we thank
Dr. Zhu and colleagues.*Robert Sheldon, MD, PhD
for the POST 2 Investigators
*Libin Cardiovascular Institute of Alberta
University of Calgary
3280 Hospital Drive NW
Calgary, Alberta T2N 4Z6
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and Diabetes MellitusWe read with interest the paper by Levelt et al. (1) in a
recent issue of the Journal, which deciphered the
parameters that give rise to ectopic fat deposition in
insulin-resistant states, such as type 2 diabetes (T2D).
One of the strengths of this study is the use of mul-
tiparametric cardiovascular and liver magnetic reso-
nance imaging (MRI), and proton and phosphorus
magnetic resonance spectroscopy, allowing a com-
parison of epicardial adipose tissue (EAT), myocardial
and hepatic triglyceride content, hepatic ﬁbroin-
ﬂammatory changes, but also cardiac function and
energetics between lean healthy and lean and obese
subjects with T2D. One of the study limitations is that
epicardial fat volume was not measured in leanhealthy subjects, so that the increase in EAT was only
validated in 33 subjects with T2D without control
subjects. However, MRI was performed in all sub-
jects, and one could expect that the authors assessed
EAT with MRI. Indeed, MRI offers excellent spatial
resolution; it is now recognized to be the gold standard
for adipose tissue imaging and superior to computed
tomography in separating epicardial from pericardial
fat, the latter of which has different vascularization
and developmental origin from EAT. Moreover, it is
also the only imaging modality in which volumetric
quantiﬁcation of EAT has been validated ex vivo (2). In
this setting of body fat distribution, the different
ectopic fat depots need to be distinguished, and we
tend to disagree with the concept of EAT as a proxy for
visceral fat. Visceral fat refers to visceral abdominal
adipose tissue and cannot be replaced by EAT, as
visceral abdominal adipose tissue ﬂexibility to
weight loss, “beiging” (brown in white adipose tissue)
molecular features, has been shown to be different
from EAT (3,4). Levelt et al. (1) evaluated different
ectopic fat depots in lean healthy and lean and obese
subjects with T2D. Nevertheless, the presence of a
body mass index <25 kg/m2 at diabetes mellitus diag-
nosis, with the current obesity epidemic, raises a
question regarding the type of diabetes. Do these lean
diabetic patients have non–type 2, secondary, or
monogenic forms of diabetes? Did the authors elimi-
nate latent autoimmune diabetes in adults, in which
the progression of ß cell failure is slow? Among
patients with phenotypic type 2 diabetes, latent
autoimmune diabetes in adults occurs in 10% of
individuals older than age 35 years (5). Further
studies are needed to determine to what extent
hyperglycemia drives speciﬁc ectopic fat deposition.*Bénédicte Gaborit, MD, PhD
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Diabetes MellitusWe thank Drs. Gaborit and Dutour for their interest in
our paper (1). We acknowledge the lack of assessment
of epicardial adipose tissue (EAT) volumes in healthy
control subjects, which was due to concerns
regarding unnecessary ionizing radiation exposure
with coronary computed tomographic angiography.
We agree that magnetic resonance imaging (MRI) is
highly suitable for adipose tissue imaging. Dark blood
prepared, T1-weighted, multislice turbo spin-echo
pulse sequence with a water suppression pre-pulse
is an established MRI technique for reliable volu-
metric measurement of EAT volumes (2). Fat quanti-
ﬁcation on the basis of steady-state free precession
cine imaging (i.e., the magnetic resonance images
available to us) is unreliable in our experience.
However, the addition of the established technique
for assessment of EAT volumes would have extended
scanning time for our participants to an unacceptable
length. Acquiring multiparametric cardiovascular and
liver magnetic resonance imaging, proton and phos-
phorus magnetic resonance spectroscopy protocol
demanded a long scanning duration. Therefore,
computed tomographic angiography, already part of
the study protocol to rule out signiﬁcant coronary
artery stenosis, was used for EAT volume quantiﬁca-
tion, which allowed imaging of the coronary arteries
and assessment of EAT volumes without additional
scan time. This is a typical example of the challenge
to ﬁnd the balance between the desirable and the
practical, regarding the amount of information we
can obtain in a clinical MRI research study.
We also agree with Gaborit and Dutour that
different fat depots need to be distinguished. EAT
shares many of the pathophysiological properties of
other visceral fat deposits and is widely considered by
the scientiﬁc community to be a proxy of visceral fat;
accordingly, we followed the nomenclature set out by
experts (3).
Regarding the differential diagnosis of type 2 dia-
betes (T2D) in lean patients, we hypothesized that
body mass index (BMI) is not a reliable measure ofexcess fat deposition, and assessing body composi-
tion, therefore, is more important in patients with
T2D than simple metrics of obesity. Consequently,
there is increasing recognition of “normal weight
obese” subjects (i.e., with increased ectopic and
visceral adiposity but normal BMI) who are prone to
the same risks of the metabolic syndrome (4). Our
study supports that view by showing that, despite a
normal BMI, patients diagnosed with T2D according
to World Health Organization criteria had evidence of
ectopic adiposity. We have not ruled out the possi-
bility of the rare condition of latent autoimmune
diabetes in adults (LADA). Although LADA patients do
not necessarily require insulin during the initial
period following diagnosis of diabetes, ultimately the
majority develop insulin dependency, usually within
6 years, due to severe impairment in b-cell function
(5). Mean diabetes duration in lean patients with T2D
in our study was 6.1  4.7 years; the majority of these
patients were treated successfully on oral antidia-
betic agents or diet control (1), whereas insulin ther-
apy is the treatment of choice for LADA (5), making
the presence of LADA unlikely. Finally, 20% of the
lean patients with T2D were of South Asian origin,
and there is strong evidence to suggest that South
Asians are more insulin resistant than Caucasians,
even at lower BMI.Eylem Levelt, MBBS, DPhil
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